Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. (CRNX) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 339 transactions totaling $157.9M, demonstrating a bearish sentiment with -$5.5M in net insider flow. The most recent transaction on Dec 26, 2025 involved a transaction of 18,000 shares valued at $34.4K.
CRNX Insider Activity Summary
Who Is Buying CRNX Stock?
No significant insider buying has been recorded for CRNX in the recent period.
Who Is Selling CRNX Stock?
No significant insider selling has been recorded for CRNX in the recent period.
Is Crinetics Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CRNX is bearish with an Insider Alignment Score of 48/100 and a net flow of -$5.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CRNX Frequently Asked Questions
Understanding CRNX Insider Activity
Insider trading at Crinetics Pharmaceuticals, Inc. (CRNX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading CRNX stock, having executed 339 transactions in the past 90 days. The most active insider is Life Sciences Master Fund Ltd Perceptive (Executive), who has made 5 transactions totaling $30.3M.
Related Tools
Track Crinetics Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at CRNX file new Form 4 transactions